Leveraging Neural Networks to Correct FoldX Free Energy Estimates.

Leveraging Neural Networks to Correct FoldX Free Energy Estimates.

Publication date: May 26, 2026

Fast and accurate prediction of folding stability and binding affinity due to protein mutations is a critical need in structural biology. While experimental methods are accurate, they are often time-consuming and costly. Computational approaches like FoldX offer fast and inexpensive alternatives by estimating free energy changes (ΔΔG) from a single 3D structure, but their accuracy remains limited. In this work, we present dFX, a neural-network-based residual correction framework that improves FoldX free energy predictions by learning from its underlying energy terms. We first assembled a collection of experimentally measured ΔΔG values and their corresponding 3D structures. Using those structures, we obtained baseline ΔΔG predictions with FoldX, along with their contributing energy terms. We then trained dFX using these FoldX energy terms as input features and a correction factor as the target, where the correction factor is the difference between experimental and FoldX ΔΔG. Our dFX models improve the prediction accuracy relative to FoldX. The dFX correction leads to improvements in Pearson correlation between experimental and predicted ΔΔG relative to FoldX across folding and binding tasks. Models trained on lower-order mutations retain predictive capability for higher-order mutations in binding. Our dFX models also lead to improvements in epistasis prediction relative to FoldX, suggesting a better capture of nonadditive effects. To test the generalizability of our models, we used an external SARS-CoV-2 data set and found that the dFX model trained on single mutations for binding outperformed FoldX and other machine-learning approaches. Once trained, our neural network models add minimal computational time but provide improvements in accuracy, making them a valuable addition to any FoldX free energy prediction pipeline. Our dFX approach could be further optimized to predict antibody escape, aiding in the efficient development of watch lists.

Open Access PDF

Concepts Keywords
Accurate
Binding
Correction
Dfx
Energy
Experimental
Foldx
Free
Improvements
Models
Mutations
Neural
Relative
Trained
“””
// Werkzeug Debugger
EVALEX = false,
EVALEX_TRUSTED = false,
in __call__
line 1536,
NotImplementedError

Semantics

Type Source Name
drug DRUGBANK Tropicamide
disease MESH cancer
drug DRUGBANK Gold
drug DRUGBANK Isoxaflutole
drug DRUGBANK Lysozyme
disease MESH dissociation
disease MESH included
drug DRUGBANK Ranitidine
disease MESH MAE
drug DRUGBANK Coenzyme M
drug DRUGBANK Amino acids
drug DRUGBANK Succimer
disease MESH strain
drug DRUGBANK Water
drug DRUGBANK Proline
drug DRUGBANK Trestolone
disease MESH Dis
drug DRUGBANK Diethylstilbestrol
disease MESH Des
disease MESH genetic diseases
disease MESH genetic susceptibility
disease MESH viral infections
disease MESH influenza
drug DRUGBANK Carboxyamidotriazole
disease MESH EL2
drug DRUGBANK Nystatin
drug DRUGBANK Tretamine
drug DRUGBANK Nonoxynol-9
drug DRUGBANK (S)-Des-Me-Ampa

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *